Table 6_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

“…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”

Table 3_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

“…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”

Table 1_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

“…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”

Table 4_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

“…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”

Data Sheet 1_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.docx by Chengli Yu (1445185)

“…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”

Table 5_Quantitative proteomic analysis reveals potential serum diagnostic markers for colorectal adenoma.xlsx by Chengli Yu (1445185)

“…The alterations in these candidate proteins were further validated by ELISA to evaluate their potential as diagnostic biomarkers for colorectal adenoma.</p>Results<p>In two independent cohorts, we identified two candidate biomarkers, apolipoprotein A4 (APOA4) and filamin A (FLNA), through a multi-step selection process involving ANOVA p-value screening, sparse partial least squares discriminant analysis (sPLS-DA), and LASSO regression analysis. …”

Simulated temporal dynamics in E2F activation using the stochastic Rb-E2F model. by Tae J. Lee (241477)

“…<p>(A) Stochastic simulations (25 events) exhibit variable time delays in E2F activation, as shown in gray lines. …”

DataSheet1_Non-target screening to track contaminant removal and release during nature-based water treatment.docx by Charlotte Guy (18392850)

“…Natural products predominantly increased after RB contact, while compounds exhibited a significant 75% decrease in peak area are mainly pharmaceuticals. …”

Table7_Non-target screening to track contaminant removal and release during nature-based water treatment.xlsx by Charlotte Guy (18392850)

“…Natural products predominantly increased after RB contact, while compounds exhibited a significant 75% decrease in peak area are mainly pharmaceuticals. …”

Table6_Non-target screening to track contaminant removal and release during nature-based water treatment.xlsx by Charlotte Guy (18392850)

“…Natural products predominantly increased after RB contact, while compounds exhibited a significant 75% decrease in peak area are mainly pharmaceuticals. …”

Transfection of catalytically active BPLF1 inhibits activation of the DDR and DNA repair in etoposide treated HeLa cells. by Jinlin Li (2267896)

“…Mean ± SE of two or three independent experiments where a minimum of 50 BPLF1 positive and 50 BPLF1 negative cells was scored in each condition.…”

Low <i>VHL</i> mRNA Expression is Associated with More Aggressive Tumor Features of Papillary Thyroid Carcinoma by Boban Stanojevic (672033)

Table_1_Bolivia's Net Zero path: Investment needs, challenges, and opportunities.XLSX by Lykke E. Andersen (3176322)

CHARACTERIZATION AND BEHAVIOUR OF PT CATALYSTS SUPPORTED ON BASIC MATERIALS IN DRY REFORMING OF METHANE by Adriana D. Ballarini (3904066)

Selective VCP inhibition induces significant cell cycle arrest in G2/M phase. by Kyla Walworth (3150936)

“…<p>(A) Following a 24-hour treatment period with control-PBS, NMS-873/DBeQ (50μM, positive-control), dendrimer (DDN) or dendrimer-encapsulated DBeQ (DDN^DBeQ, 50 μM), cells were fixed with ice-cold 70%-ethanol followed by staining with propidium iodide (10μg/mL) for 1 hour. …”

Table_1_Understanding Thermostability Factors of Barley Limit Dextrinase by Molecular Dynamics Simulations.DOCX by Juan Du (118107)

Sertoli cell-specific ablation in adulthood. by Diane Rebourcet (153547)

“…<p>(A) Amh-Cre;iDTR model. (B) DTR expression is restricted to Sertoli cells (scale bar: 50 µm). …”

Image_2_Understanding Thermostability Factors of Barley Limit Dextrinase by Molecular Dynamics Simulations.tif by Juan Du (118107)

Down syndrome: Prevalence and distribution of congenital heart disease in Brazil by Beatriz Elizabeth Bagatin Veleda Bermudez (12799493)

“…DESIGN AND SETTING : Cross-sectional study conducted in a referral center. METHODS : Data were retrospectively gathered from the medical files of 1,207 patients with Down syndrome, among whom 604 (50.0%) had been diagnosed with congenital heart disease. …”

TbCDC34 activity is modulated by compound CC0651. by Federico Rojas (480253)